These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15330264)

  • 1. Incidence of extended-spectrum beta-lactamases in clinical isolates of the family Enterobacteriaceae in a pediatric hospital.
    Halina RK; Marek G; Danuta RZ; Maria N; Maria R; Barbara W; Gayane M
    Pol J Microbiol; 2004; 53(1):27-34. PubMed ID: 15330264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of Vitek 2 performance for identifying extended spectrum beta-lactamases in Enterobacteriaceae "other than Escherichia coli, Proteus mirabilis and Klebsiella spp"].
    Diamante P; Camporese A
    Infez Med; 2006 Dec; 14(4):216-26. PubMed ID: 17380089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and typing of extended-spectrum beta-lactamases in clinical isolates of the family Enterobacteriaceae in a medical center in Turkey.
    Durmaz R; Durmaz B; Koroglu M; Tekerekoglu MS
    Microb Drug Resist; 2001; 7(2):171-5. PubMed ID: 11442343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
    Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of extended spectrum beta-lactamases-producing isolates and effect of AmpC overlapping.
    Hassan MI; Alkharsah KR; Alzahrani AJ; Obeid OE; Khamis AH; Diab A
    J Infect Dev Ctries; 2013 Aug; 7(8):618-29. PubMed ID: 23949298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and extended-spectrum beta-lactamases of Hong Kong isolates of enterobacteriaceae.
    Lyon DJ; Scheel O; Adeyemi-Doro FA; Ling TK; Cheng AF; Norrby SR
    Scand J Infect Dis Suppl; 1996; 101():17-20. PubMed ID: 9060047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests.
    Navon-Venezia S; Hammer-Munz O; Schwartz D; Turner D; Kuzmenko B; Carmeli Y
    J Clin Microbiol; 2003 Jan; 41(1):155-8. PubMed ID: 12517841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011.
    Hoban DJ; Badal R; Bouchillon S; Hackel M; Kazmierczak K; Lascols C; Hawser S
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):367-72. PubMed ID: 24813688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of extended-spectrum beta-lactamases and drug sensitivity test in clinical isolates of the family Enterobacteriaceae in Shanghai].
    Lin Q; Luo W; Xiu Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):420-2. PubMed ID: 11778509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-lactamases of clinical isolates of Enterobacteriaceae family].
    Polishko TM; Skliar TV; Krysenko OV; Vinnikov AI; Kudriavtseva VIe
    Mikrobiol Z; 2011; 73(2):20-5. PubMed ID: 21598655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae: an Italian survey.
    Bonfiglio G; Perilli M; Stefani S; Amicosante G; Nicoletti G
    Int J Antimicrob Agents; 2002 Mar; 19(3):213-7. PubMed ID: 11932144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.